Non-Hodgkin's lymphoma of the testicle and bilateral adrenals detected by 18F-FDG PET/CT

Yin,Yafu; Qing,Feng; Li,Xuena; Du,Bulin; Li,Na; Li,Yaming

doi:10.3892/etm.2011.300

Non-Hodgkin's lymphoma of the testicle and bilateral adrenals detected by 18F-FDG PET/CT

Authors:
- Yafu Yin
- Feng Qing
- Xuena Li
- Bulin Du
- Na Li
- Yaming Li
View Affiliations

Affiliations: Department of Nuclear Medicine, The First Hospital of China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China, Nuclear Medicine, William Beaumont Hospital, Troy, MI, USA, Department of Nuclear Medicine, The First Hospital of China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China
Published online on: June 29, 2011 https://doi.org/10.3892/etm.2011.300
Pages: 817-820

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lymphoma, particularly non-Hodgkin's lymphoma, may occur in sites other than the lymph nodes, i.e., extranodal lymphoma, which occurs in approximately 40% of total lymphoma cases. However, simultaneous detection of multiple extranodal involvements at presentation is quite uncommon. Here, we report a rare case of a 55-year-old Chinese man with non-Hodgkin's lymphoma of the left testicle and bilateral adrenals as determined by 18F-FDG PET/CT imaging. FDG PET/CT has been successfully employed for lymphoma diagnosis, initial staging, restaging and therapy follow-up. It is useful for assessing both nodal and extranodal involvements. In the present case of lymphoma with involvement of the testicle and bilateral adrenals, 18F-FDG PET/CT played an important role in the diagnosis and assessment of therapeutic response.

View Figures

View References

1.	Lu P: Staging and classification of lymphoma. Semin Nucl Med. 35:160–164. 2005. View Article : Google Scholar
2.	Metser U, Goor O, Lerman H, Naparstek E and Even-Sapir E: PET-CT of extranodal lymphoma. AJR Am J Roentgenol. 182:1579–1586. 2004. View Article : Google Scholar : PubMed/NCBI
3.	Economopoulos T, Papageorgiou S, Rontogianni D, et al: Multifocal extranodal non-Hodgkin lymphoma: a clinicopathological study of 37 cases in Greece, a Hellenic Cooperative Oncology Group Study. The Oncologist. 10:734–738. 2005. View Article : Google Scholar : PubMed/NCBI
4.	Shahab N and Doll DC: Testicular lymphoma. Semin Oncol. 26:259–269. 1999.
5.	Touroutoglou N, Dimopoulos MA, Younes A, et al: Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol. 13:1361–1367. 1995.PubMed/NCBI
6.	Ballen KK and Hasserjian RP: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2004 A 31-year-old man with bilateral testicular enlargement. N Engl J Med. 350:2081–2087. 2004.
7.	Kubo M, Koga M, Fujii T, Kaneko T, Yamashita K and Kokubu T: Bilateral adrenal lymphoma with neoplastic angioendotheliosis. Intern Med. 36:47–52. 1997. View Article : Google Scholar : PubMed/NCBI
8.	Rosenberg SA, Diamond HD, Jaslowitz B and Craver LF: Lymphosarcoma: a review of 1269 cases. Medicine. 40:31–84. 1961. View Article : Google Scholar : PubMed/NCBI
9.	Lee MJ, Hahn PF, Papanicolaou N, Egglin TK, Saini S, Mueller PR and Simeone JF: Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology. 179:415–418. 1991. View Article : Google Scholar : PubMed/NCBI
10.	Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM and Mueller PR: Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol. 171:201–204. 1998. View Article : Google Scholar : PubMed/NCBI
11.	Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR and Raghupathi KI: Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology. 222:629–633. 2002. View Article : Google Scholar : PubMed/NCBI
12.	Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR and Kazerooni EA: Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 166:531–536. 1996. View Article : Google Scholar : PubMed/NCBI
13.	Paul R: Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J Nucl Med. 28:288–292. 1987.PubMed/NCBI
14.	Elstrom R, Guan L, Baker G, et al: Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 101:3875–3876. 2003. View Article : Google Scholar : PubMed/NCBI
15.	Allen-Auerbach M, de Vos S and Czernin J: The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiol Clin North Am. 46:199–211. 2008. View Article : Google Scholar
16.	Lam WW and Osmany S: Biliary non-Hodgkin lymphoma detected by F-18 FDG PET/CT. Clin Nucl Med. 34:791–792. 2009. View Article : Google Scholar : PubMed/NCBI
17.	Bosch-Barrera J, Arbea L, García-Velloso MJ, Gil-Bazo I, García-Foncillas J and Panizo C: Primary bone lymphoma of the mandible and thyroid incidentaloma identified by FDG PET/ CT: a case report. Cases J. 26:63842009.PubMed/NCBI
18.	Juweid ME, Stroobants S, Hoekstra OS, et al: Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 25:571–578. 2007. View Article : Google Scholar
19.	Hutchings M and Barrington SF: PET/CT for therapy response assessment in lymphoma. J Nucl Med. 50:S21–S30. 2009. View Article : Google Scholar
20.	Podoloff DA, Advani RH, Allred C, et al: NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw. 5(Suppl 1): 1–22. 2007.PubMed/NCBI
21.	Juweid ME: FDG-PET/CT in lymphoma. Methods Mol Biol. 727:1–19. 2011. View Article : Google Scholar : PubMed/NCBI